FDA Adverse Event Malfunction Summary report: N

PAB®

MDR report key: 12810914 · Received November 15, 2021

Report

Report Number
2021236-2021-00012
Event Type
Malfunction
Date Received
November 15, 2021
Date of Event
November 2, 2021
Report Date
May 27, 2022
Manufacturer
B. BRAUN MEDICAL INC
Product Code
KPE
UDI-DI
04046964187698
PMA / PMN Number
K840388
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN MEDICAL INC. INTERNAL REPORT NUMBER (B)(4). ONE (1) EMPTY PAB UNIT WAS RECEIVED FROM BATCH J1E651 FOR EVALUATION. A BLACK PARTICULATE MATTER WAS OBSERVED INSIDE THE UNIT. A SINGLE PUNCTURE WAS OBSERVED IN THE UNDERSIDE OF THE STOPPER. THERE WAS NO VISIBLE EVIDENCE OF STOPPER MATERIAL MISSING (CORING) DUE TO NEEDLE INSERTION AT THE ENTRY OR EXIT POINT OF THE STOPPER. THE PARTICLE INSIDE THE EMPTY PAB BAG WAS IDENTIFIED AS BUTYL RUBBER WHICH IS THE MATERIAL IN RUBBER STOPPERS. SINCE THE MATERIAL THE PAB STOPPER IS THE MOST COMMON MATERIAL SOLD IN THE US FOR DRUG VIALS, IT IS POSSIBLE THE PM PARTICLE CAME FROM ANOTHER SOURCE OF CORING (STOPPER) THAT WAS INJECTED INTO THE EMPTY PAB BAG THROUGH THE LUMEN OF THE NEEDLE WHEN MEDICATION WAS ADDED. INVESTIGATION SHOWS THE SOURCE OF THE CORE IS NOT THE PAB CONTAINER (STOPPER) RETURNED. TYPICALLY, THERE WOULD BE EVIDENCE SUCH AS MISSING MATERIAL OR FRAGMENT IN THE TOP OR BOTTOM SIDE OF THE STOPPER IF THE CORE WERE FROM THE RETURNED SAMPLE. A REVIEW OF OUR DISCREPANCY MANAGEMENT SYSTEM DATABASE FOUND NO RELATED OR SIMILAR DISCREPANCIES DURING THE PRODUCTION OF THE BATCH. VISUAL INSPECTION ON TWENTY (20) RETAINED UNITS REVEALED THAT NO PARTICULATE MATTER WAS OBSERVED IN ANY OF THE RETAINED UNITS.

Additional Manufacturer Narrative · 0

THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN MEDICAL INC. INTERNAL REPORT NUMBER (B)(4). THE DEVICE INVOLVED HAS NOT BEEN RECEIVED FOR EVALUATION AND THE INVESTIGATION IS ONGOING AT THIS TIME. A FOLLOW UP WILL BE SUBMITTED WHEN THE INVESTIGATION RESULTS BECOME AVAILABLE.

Description of Event or Problem · 0

AS REPORTED BY THE USER FACILITY: AFTER COMPOUNDING FENTANYL INTO THE PAB BAG A DARK COLORED PARTICLE WAS FOUND IN THE SOLUTION. NO INJURIES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1715453 PAB® CONTAINER, IV KPE B. BRAUN MEDICAL INC S5904-52 J1E651 04046964187698

Patients

Seq Age Sex Outcome Treatment
1 Unknown